Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03271580 · ClinicalTrials.gov registry record

Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing

A clinical trial, sponsored by Indiana University.

Terminated
Registry status
31
Enrollment target

NCT03271580: Clinical Trial study, sponsored by Indiana University.

NCT03271580 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03271580 was terminated before completion, sponsored by Indiana University.

TERMINATED
Registry status
31 participants
Enrollment target

Study Summary

The purpose of this study is to learn more about biofilm and to see how it affects diabetic wounds. A biofilm can occur if a chronic infection causes bacteria to grow in a slime enclosed group. This grouping of bacteria is called a biofilm.

Primary Outcome

Biofilm Infection using SEM and RT PCR analysis

Interventions

  • PROCEDURE Punch Biopsy
  • OTHER Ankle Brachial Index
  • DIAGNOSTIC_TEST Finger prick test for HbA1c measurement
  • OTHER Vac Sponge Collection

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2020-02-01
Est. Completion 2021-09-13
Indiana University

890 total trials

Why NCT03271580 stopped before completion

NCT03271580 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.

The record links to 0 conditions, and to 4 interventions - of which Punch Biopsy is the first listed.

NCT03271580 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03271580 about?

NCT03271580 is a clinical study titled "Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing". The purpose of this study is to learn more about biofilm and to see how it affects diabetic wounds. A biofilm can occur if a chronic infection causes bacteria to grow in a slime enclosed group. This grouping of bacteria is called a biofilm.

What is the current status of trial NCT03271580?

This trial is currently terminated. The enrollment target is 31 participants. The study started on 2020-02-01. Estimated completion is 2021-09-13.

What interventions are being tested in trial NCT03271580?

The interventions under investigation include: Punch Biopsy (PROCEDURE), Ankle Brachial Index (OTHER), Finger prick test for HbA1c measurement (DIAGNOSTIC_TEST), Vac Sponge Collection (OTHER).

Who is sponsoring clinical trial NCT03271580?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03271580, the US trial registry maintained by the National Library of Medicine. NCT03271580 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.